This is a portion (1 of 6 observations) of a much longer Employer Healthcare Benefits article which would have been impossible to feature in entirety at AB. If I did so, much of it would probably go unread. I was interested in how much concern employees have about company healthcare insurance costs. In particular, I was looking at what employees thought about their plans and its affordability as show in chart 6. Costs, Inflation and Affordability...
Read More »A Look at Drug Pricing 2020, Costs, and Why – “Redux”
Commenter Arne asked how we would transition from today’s healthcare system to a Single Payer format. I do not have the answer immediately at hand. I have to look for it. I do want to review what we have learned to date and stated on Angry Bear already. I do have a number of posts of the costs of healthcare. This one I like as it is simple and gets the point across on Drug Costs. I recently did a post of Pharma pricing which I will conclude with...
Read More »A Look at Drug Pricing 2020, Costs, and Why “Redux”
I had written on the high cost of pharmaceuticals late 2019, “Another Look at Drug Pricing, Costs, and Why” citing from the World Health Organization, the ICER, JAMA Network, Health Affairs, and my own posts (links below and in text). You will find the some of the same articles cited in new commentary of increased drug costs in the Washington Post, Kaiser Health News, and Medpage Today. It appears the three of them have caught up with Angry Bear’s...
Read More »Again, Healthcare Cost Drivers Pharma, Doctors, and Hospitals
This should come as no surprise as I have written on the topic of Healthcare Costs and Its Drivers before. In particular, the overriding statistic from an earlier post was 50% of the increase in healthcare costs was due solely to price increases between 1996 and 2013 (JAMA, Factors Associated With . . . . Adjusting for inflation, “annual health care spending on inpatient, ambulatory, retail pharmaceutical, nursing facility, emergency department, and...
Read More »